Arteon Bio

Seongnam-si, South Korea Founded: 2022 • Age: 4 yrs
Immunotherapies for cancer are developed by regulating the tumor microenvironment.

About Arteon Bio

Arteon Bio is a Healthcare company based in Seongnam-si (South Korea) founded in 2022 by Sohee Choi. Immunotherapies for cancer are developed by regulating the tumor microenvironment. Its chief executive, as recorded, is Sohee Choi. Arteon Bio offers products and services including ATN001, ATN002, and ATN003. Its focus areas include Life Sciences, Oncology, Drugs and Diversified. Its legal entity in India is μ•„ν…Œμ˜¨λ°”μ΄μ˜€(μ£Ό) (U99999MH1977PLC010754).

Company details

Arteon Bio was founded in 2022 in Seongnam-si, South Korea, within the biotechnology sector. Anti-tumor therapeutics are developed to treat cancer through regulation of the tumor microenvironment. Focus is placed on immunotherapies that modulate immune responses in oncology. Operations involve research and development of targeted treatments, with activities based in South Korea to support global cancer care advancements.

  • Headquarters Seongnam-si, South Korea
  • Founders Sohee Choi
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website atheonbio.com
  • Social LinkedIn
  • Legal Name 아테온바이오(주)
  • Date of Incorporation 10 Aug, 1977
  • Jurisdiction Maharashtra, India
Key Metrics

Products & Services of Arteon Bio

Arteon Bio offers a comprehensive portfolio of products and services, including ATN001, ATN002, and ATN003.

ATN001
Biotech Product

Pipeline item for biotechnology research and development

ATN002
Biotech Product

Another item in the technology pipeline

ATN003
Biotech Product

Third element in scientific development pipeline

Funding Insights of Arteon Bio

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Arteon Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2024Seed––
Valuation history

1 investors in total: 1 institutional.

Investors in Arteon Bio

Arteon Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HLB.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Marine composite materials are manufactured for industry applications.
1985hlbkorea.comUlsan, South Korea
Premium access

Investor details for Arteon Bio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Arteon Bio

1 people are tracked at Arteon Bio (1 in leadership).

NameRoleGroup
Sohee Choi
Founder & CEOLeadership
Premium access

Complete people profiles for Arteon Bio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Arteon Bio

2 dated milestones of Arteon Bio across 2 years, from founding to its latest funding, stage changes and deals.

  1. Founded Arteon Bio is founded.
  2. Funding First funding round.

Web traffic of Arteon Bio

The website of Arteon Bio (atheonbio.com) receives about 2.8K visits a month.

  • Monthly visits
    2.8K

    ▲ 116.7% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Arteon Bio

Premium access

Complete news archive for Arteon Bio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arteon Bio

Arteon Bio was founded in 2022 and raised its 1st funding round 2 years after it was founded.

Arteon Bio is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.

Sohee Choi is the CEO of Arteon Bio, as recorded in our data. They have also founded this company.

Arteon Bio was founded in 2022 in Seongnam-si, South Korea, within the biotechnology sector. Anti-tumor therapeutics are developed to treat cancer through regulation of the tumor microenvironment. Focus is placed on immunotherapies that modulate immune responses in oncology. Operations involve research and development of targeted treatments, with activities based in South Korea to support global cancer care advancements.

Arteon Bio offers ATN001, ATN002, and ATN003.

Arteon Bio has 1 investor. Key investors include HLB.

Arteon Bio operates through ,.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available